Bivalirudin
NDC 63323-562 · Fresenius Kabi USA, LLC
FDA carries 2 listing records for this NDC; the most recent is shown.
Packages
63323-562-10 — 10 VIAL, SINGLE-USE in 1 CARTON (63323-562-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE
63323-562-15 — 10 VIAL, SINGLE-USE in 1 CARTON (63323-562-15) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (63323-562-41)
Billed under HCPCS
J0583 — Injection, bivalirudin, 1 mg Medicare Part B payment limit (ASP + 6%): $0.17
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0781-3158 — bivalirudin, 16729-275 — bivalirudin, 42023-622 — Bivalirudin, 52958-034 — Bivalirudin, 55111-652 — Bivalirudin, 55150-210 — BIVALIRUDIN, 67457-256 — bivalirudin, 70436-025 — bivalirudin, 70511-142 — Bivalirudin, 71288-427 — BIVALIRUDIN, 72572-035 — bivalirudin, 83634-400 — bivalirudin
Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels
Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources